Entering text into the input field will update the search result below

Chardan bullish on MeiraGTx after JNJ investment; shares up 14%

Feb. 27, 2019 10:46 AM ETMeiraGTx Holdings plc (MGTX) StockMGTXBy: Douglas W. House, SA News Editor
  • Chardan Capital Markets reiterates its Buy rating on gene therapy developer MeiraGTx (MGTX +14.4%) with a more bullish price target of $40 (165% upside) (from $30) after it announced a stake by a group led by Johnson & Johnson's investment arm.
  • J&J does not have a presence in the areas targeted by the company, including wet AMD, radiation-induced xerostomia, Sjogren's syndrome, advanced Parkinson's and ALS.

Recommended For You

More Trending News

About MGTX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MGTX--
MeiraGTx Holdings plc